Myocardial expression, signaling, and function of GPR22: a protective role for an orphan G protein-coupled receptor.

G protein-coupled receptors (GPCRs) play an essential role in the regulation of cardiovascular function. Therapeutic modulation of GPCRs has proven to be beneficial in the treatment of human heart disease. Myocardial "orphan" GPCRs, for which the natural ligand is unknown, represent potential novel therapeutic targets for the treatment of heart disease. Here, we describe the expression pattern, signaling pathways, and possible physiological role of the orphan GPR22. GPR22 mRNA analysis revealed a highly restricted expression pattern, with remarkably abundant and selective expression in the brain and heart of humans and rodents. In the heart, GPR22 mRNA was determined to be expressed in all chambers and was comparable with transcript levels of the beta(1)-adrenergic receptor as assessed by Taqman PCR. GPR22 protein expression in cardiac myocytes and coronary arteries was demonstrated in the rat heart by immunohistochemistry. When transfected into HEK-293 cells, GPR22 coupled constitutively to G(i)/G(o), resulting in the inhibition of adenyl cyclase. No constitutive coupling to G(s) or G(q) was observed. Myocardial mRNA expression of GPR22 was dramatically reduced following aortic banding in mice, suggesting a possible role in response to the stress associated with increased afterload. The absence of detectable GPR22 mRNA expression in the hearts of GPR22(-/-) mice had no apparent effect on normal heart structure or function; however, these mice displayed increased susceptibility to functional decompensation following aortic banding. Thus, we described, for the first time, the expression pattern and signaling for GPR22 and identified a protective role for GPR22 in response to hemodynamic stress resulting from increased afterload.

[1]  R. Lefkowitz,et al.  Signalling: Seven-transmembrane receptors , 2002, Nature Reviews Molecular Cell Biology.

[2]  K. Chien,et al.  Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes , 2001, Nature Medicine.

[3]  Y. Hakak,et al.  Global analysis of G‐protein‐coupled receptor signaling in human tissues , 2003, FEBS letters.

[4]  W. Colucci,et al.  Effects of intracoronary acetylcholine and atropine on basal and dobutamine-stimulated left ventricular contractility. , 1994, Circulation.

[5]  E. Fleck,et al.  Angiotensin receptor type 1 mRNA in human right ventricular endomyocardial biopsies: downregulation in heart failure. , 1997, Cardiovascular research.

[6]  W. Flameng,et al.  Adenosine, adenosine receptors and myocardial protection: an updated overview. , 2001, Cardiovascular research.

[7]  E. Lucchinetti,et al.  Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. , 2000, Circulation.

[8]  Albert Zlotnik,et al.  Effects of RNA degradation on gene expression analysis of human postmortem tissues , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  J. Peart,et al.  Adenosinergic cardioprotection: multiple receptors, multiple pathways. , 2007, Pharmacology & therapeutics.

[10]  John W. Adams,et al.  G-proteins in growth and apoptosis: lessons from the heart , 2001, Oncogene.

[11]  K. Chien,et al.  Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes. , 2001, Nature medicine.

[12]  S. O’Gorman,et al.  Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Harding,et al.  The effect of pertussis toxin on β‐adrenoceptor responses in isolated cardiac myocytes from noradrenaline‐treated guinea‐pigs and patients with cardiac failure , 1992, British journal of pharmacology.

[14]  M. Böhm,et al.  Antiadrenergic effect of M-cholinoceptor stimulation on human ventricular contractility in vivo. , 1992, The American journal of physiology.

[15]  K. Chien,et al.  Erratum: Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy (Proc. Natl. Acad. Sci. USA (September 1991) 88 (8277-8281)) , 1991 .

[16]  L. Burget,et al.  Effect of central administration of QRFP(26) peptide on energy balance and characterization of a second QRFP receptor in rat , 2006, Brain Research.

[17]  Prahlad T. Ram,et al.  G Protein Pathways , 2002, Science.

[18]  A. Mondry,et al.  Decrease in β1-adrenergic and M2-muscarinic receptor mRNA levels and unchanged accumulation of mRNAs coding for Gαi‒2 and Gαs proteins in rat cardiac hypertrophy , 1995 .

[19]  E. Lakatta,et al.  The β2-Adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through Gi-Dependent coupling to phosphatidylinositol 3'-kinase , 2000 .

[20]  J. Ornato,et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[21]  L. Ignarro,et al.  Nitric oxide reduces early growth response-1 gene expression in rat lung macrophages treated with interferon-gamma and lipopolysaccharide. , 1994, The Journal of biological chemistry.

[22]  J. Ross,et al.  Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[23]  E. Winstall,et al.  Rapid mRNA degradation mediated by the c-fos 3' AU-rich element and that mediated by the granulocyte-macrophage colony-stimulating factor 3' AU-rich element occur through similar polysome-associated mechanisms , 1995, Molecular and cellular biology.

[24]  G. Shaw,et al.  Translational blockade imposed by cytokine-derived UA-rich sequences. , 1989, Science.

[25]  M David Tilson,et al.  The polymorphonuclear leukocyte and the abdominal aortic aneurysm: a neglected cell type and a neglected disease. , 2005, Circulation.

[26]  Catherine Communal,et al.  Opposing Effects of β1- and β2-Adrenergic Receptors on Cardiac Myocyte Apoptosis Role of a Pertussis Toxin–Sensitive G Protein , 1999 .

[27]  G. Newton,et al.  Muscarinic receptor modulation of basal and beta-adrenergic stimulated function of the failing human left ventricle. , 1996, The Journal of clinical investigation.

[28]  J. Ross,et al.  Transthoracic echocardiography in models of cardiac disease in the mouse. , 1996, Circulation.

[29]  D. Behan,et al.  The use of constitutively active GPCRs in drug discovery and functional genomics , 2002, Nature Reviews Drug Discovery.

[30]  G. Gross,et al.  Opioids and cardioprotection. , 2001, Pharmacology & therapeutics.

[31]  Brian K. Kobilka,et al.  Organization of β-adrenoceptor signaling compartments by sympathetic innervation of cardiac myocytes , 2007, The Journal of cell biology.

[32]  J. Gutkind,et al.  G-protein-coupled receptors and signaling networks: emerging paradigms. , 2001, Trends in pharmacological sciences.

[33]  H. Heng,et al.  Cloning and chromosomal mapping of four putative novel human G-protein-coupled receptor genes. , 1997, Gene.

[34]  R. Gibbons,et al.  A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). , 2005, Journal of the American College of Cardiology.

[35]  R. Califf,et al.  Myocardial Infarction Adenosine as an Adjunct to Thrombolytic Therapy for Acute Myocardial Infarction , 1999 .

[36]  V. V. Empel,et al.  Myocyte hypertrophy and apoptosis: a balancing act. , 2004 .

[37]  W. Koch,et al.  Enhanced calcium cycling and contractile function in transgenic hearts expressing constitutively active G alpha o* protein. , 2008, American journal of physiology. Heart and circulatory physiology.

[38]  E. Lucchinetti,et al.  β-Adrenergic Receptor Subtypes Differentially Affect Apoptosis in Adult Rat Ventricular Myocytes , 2000 .

[39]  C. Y. Chen,et al.  mRNA decay mediated by two distinct AU-rich elements from c-fos and granulocyte-macrophage colony-stimulating factor transcripts: different deadenylation kinetics and uncoupling from translation , 1995, Molecular and cellular biology.

[40]  S. Sasayama,et al.  Up-regulated expression of angiotensin II type 1 receptor gene in human pathologic hearts. , 1997, Journal of cardiac failure.

[41]  R. Atkins,et al.  A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens. , 1995, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[42]  Robert J. Lefkowitz,et al.  Seven-transmembrane-spanning receptors and heart function , 2002, Nature.

[43]  H. Matsubara,et al.  Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. , 1995, The Journal of clinical investigation.

[44]  David M. Harris,et al.  Targeted Inhibition of Cardiomyocyte Gi Signaling Enhances Susceptibility to Apoptotic Cell Death in Response to Ischemic Stress , 2008, Circulation.